Business
The end of 23andMe’s drug discovery dream - STAT
23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business challenges, announced it would lay off 40% of its workforce.
By: STAT
- Nov 13 2024
- 0
- 0 Views
23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business challenges, announced Monday that it would halt its efforts to develop new medic… [+1003 chars]